ArticleInternal medicine (Tokyo, Japan)2020

Refractory Ulcerative Colitis Improved by Scheduled Combination Therapy of Vedolizumab and Granulocyte and Monocyte Adsorptive Apheresis.

Masanao Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.